121 – 130 of 557
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
- Contribution to journal › Article
-
Mark
Designing and Implementing a Population-based Organised Prostate Cancer Testing Programme
- Contribution to journal › Article
-
Mark
Experimental in vivo model to evaluate the impact of Cernitin™ on pain response on induced chronic bladder inflammation
- Contribution to journal › Article
-
Mark
EANM-EAU consensus on PSMA PET/CT in respect to radioligand therapy ([177Lu]Lu-PSMA)
- Contribution to journal › Debate/Note/Editorial
-
Mark
Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
- Contribution to journal › Article
-
Mark
Robot-assisted nephroureterectomy for upper tract urothelial carcinoma—feasibility and complications : a single center experience
- Contribution to journal › Article
-
Mark
The STAT3 inhibitor GPB730 enhances the sensitivity to enzalutamide in prostate cancer cells
- Contribution to journal › Article
-
Mark
Plasma and Urine Free Glycosaminoglycans as Monitoring Biomarkers in Nonmetastatic Renal Cell Carcinoma—A Prospective Cohort Study
- Contribution to journal › Article
-
Mark
Diagnostic and prognostic factors in patients with prostate cancer : a systematic review
- Contribution to journal › Scientific review
-
Mark
European Association of Urology Guidelines on Renal Cell Carcinoma : The 2022 Update
- Contribution to journal › Scientific review
